Gender equity in mass drug administration for neglected tropical diseases: Data from 16 countries

Margaret Cameron Baker; Kathryn Lee Zoerhoff; Lisa Ann Rotondo; Kalpana Bhandari; Maureen Priscilla Kelly; Daniel Albert Cohn; Rachel Dee Stelmach; Pia Columbine Mingkwan; Upendo John Mwingira; Daniel Cohn; Maureen Priscilla Kelly; Kalpana Bhandari; Kathryn Lee Zoerhoff; Wilfrid E Batcho; François Drabo; Nebiyu Negussu; Benjamin Marfo; André Goepogui; Jean Frantz Lemoine; Sitti Ganefa; Marilia Massangaie; Pradip Rimal; Issah Gnandou; Ifeoma N. Anagbogu; Mamadou Ndiaye; Yakuba Madina Bah; Upendo John Mwingira; Marcel S Awoussi; Edridah Muheki Tukahebwa; Rachel Dee Stelmach; Pia Columbine Mingkwan; Bolivar Pou; Joseph B Koroma; Lisa Ann Rotondo; John D Kraemer; Margaret Cameron Baker

Gender equity in mass drug administration for neglected tropical diseases

Data from 16 countries

Cohn, D. A., Kelly, M. P., Bhandari, K., Zoerhoff, K. L., Batcho, W. E., Drabo, F., Negussu, N., Marfo, B., Goepogui, A., Lemoine, J.-F., Ganefa, S., Massangaie, M., Rimal, P., Gnandou, I., Anagbogu, I. N., Ndiaye, M., Bah, Y. M., Mwingira, U. J., Awoussi, M. S., ... Baker, M. C. (2019). Gender equity in mass drug administration for neglected tropical diseases: Data from 16 countries. International Health, 11(5), 370-378. https://doi.org/10.1093/inthealth/ihz012

Copy citation

Abstract

BACKGROUND: Gender equity in global health is a target of the Sustainable Development Goals and a requirement of just societies. Substantial progress has been made towards control and elimination of neglected tropical diseases (NTDs) via mass drug administration (MDA). However, little is known about whether MDA coverage is equitable. This study assesses the availability of gender-disaggregated data and whether systematic gender differences in MDA coverage exist.

METHODS: Coverage data were analyzed for 4784 district-years in 16 countries from 2012 through 2016. The percentage of districts reporting gender-disaggregated data was calculated and male-female coverage compared.

RESULTS: Reporting of gender-disaggregated coverage data improved from 32% of districts in 2012 to 90% in 2016. In 2016, median female coverage was 85.5% compared with 79.3% for males. Female coverage was higher than male coverage for all diseases. However, within-country differences exist, with 64 (3.3%) districts reporting male coverage >10 percentage points higher than female coverage.

CONCLUSIONS: Reporting of gender-disaggregated data is feasible. And NTD programs consistently achieve at least equal levels of coverage for women. Understanding gendered barriers to MDA for men and women remains a priority.